![Jennifer Locke](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Jennifer Locke
Directeur des opérations chez ClearB Therapeutics, Inc.
Profil
Jennifer Locke currently works at ClearB Therapeutics, Inc., as Chief Operating & Business Officer and Adiso Therapeutics, Inc., as Chief Operating & Business Officer from 2022.
Postes actifs de Jennifer Locke
Sociétés | Poste | Début |
---|---|---|
ClearB Therapeutics, Inc.
![]() ClearB Therapeutics, Inc. BiotechnologyHealth Technology ClearB Therapeutics, Inc. is a company that focuses on therapeutics. The company is based in Concord, MA. The company was co-founded in 2017 by Morningside Ventures in collaboration with Professor Stephen Locarnini and the Victoria Infectious Diseases Reference Laboratory. Aileen Rubio has been the CEO of the company since 2018. | Directeur des opérations | - |
Adiso Therapeutics, Inc.
![]() Adiso Therapeutics, Inc. BiotechnologyHealth Technology Adiso Therapeutics, Inc. creates medicines to treat inflammatory diseases with the goal of improving the lives of patients and their families. Adiso Therapeutics is based in Concord, MA. The company believes that current therapeutic approaches are often inadequate and can pose significant safety concerns for patients. Scott T. Megaffin has been the CEO of the company since 2022. | Directeur des opérations | 01/01/2022 |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
Entreprise privées | 2 |
---|---|
ClearB Therapeutics, Inc.
![]() ClearB Therapeutics, Inc. BiotechnologyHealth Technology ClearB Therapeutics, Inc. is a company that focuses on therapeutics. The company is based in Concord, MA. The company was co-founded in 2017 by Morningside Ventures in collaboration with Professor Stephen Locarnini and the Victoria Infectious Diseases Reference Laboratory. Aileen Rubio has been the CEO of the company since 2018. | Health Technology |
Adiso Therapeutics, Inc.
![]() Adiso Therapeutics, Inc. BiotechnologyHealth Technology Adiso Therapeutics, Inc. creates medicines to treat inflammatory diseases with the goal of improving the lives of patients and their families. Adiso Therapeutics is based in Concord, MA. The company believes that current therapeutic approaches are often inadequate and can pose significant safety concerns for patients. Scott T. Megaffin has been the CEO of the company since 2022. | Health Technology |